CXCL9 and primary biliary cholangitis: Th1 cytokines and chemokines, including IFN-γ, chemokine (C-X-C motif) ligand 9, and IFN-γ-induced protein-10, were increased in PBC patients and were reduced after ursodeoxycholic acid treatment [35].